PLGA-coated Biphasic Calcium Phosphate in Sinus Lift
Sinus Floor Elevation Using Particulate and in Situ Hardening Biphasic Calcium Phosphate Bone Graft Substitutes: A Prospective Histological and Radiological Study
1 other identifier
interventional
36
1 country
2
Brief Summary
The study aims to investigate the radiological and histomorphometric results of the use of PLGA-coated biphasic calcium phosphate granules in sinus floor elevation, to analyze the underlying molecular processes by immunohistochemical staining, and to evaluate the handling of the biomaterial and the in situ hardening properties. A randomized clinical study is designed to include patients in need of two-stage sinus floor elevation. Patients are assigned to receive either PLGA-coated biphasic calcium phosphate particles (group I) or the equivalent but non-coated particles (group II). CBCT scans are performed before and 6 months after the procedure to assess the bone height gain. At the time of implant placement, bone core biopsies are obtained at the site of implant placement. Histological sections are subjected to histomorphometric and immunohistochemical evaluation of differentiation markers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2012
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2017
CompletedFirst Submitted
Initial submission to the registry
March 15, 2018
CompletedFirst Posted
Study publicly available on registry
March 22, 2018
CompletedMarch 22, 2018
March 1, 2018
2.1 years
March 15, 2018
March 15, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Sinus floor height change
CBCT scans are performed before the sinus floor elevation and 6 months later before implant placement to measure vertical bone height from the crestal bone to the floor of the maxillary sinus.
6 months
Secondary Outcomes (3)
Area of new mineralized tissue
6 months
Area of non-mineralized tissue
6 months
Area of remaining graft particles
6 months
Study Arms (2)
Non-coated HA/TCP particles
ACTIVE COMPARATORBiphasic hydroxyapatite and beta-tricalcium phosphate bone graft
PLGA-coated HA/TCP particles
EXPERIMENTALBiphasic hydroxyapatite and beta-tricalcium phosphate bone graft with PLGA coating
Interventions
Maxillary sinus floor elevation and bone grafting with the use of biphasic hydroxyapatite and beta-tricalcium phosphate bone graft
Maxillary sinus floor elevation and bone grafting with the use of biphasic hydroxyapatite and beta-tricalcium phosphate bone graft with PLGA coating
Eligibility Criteria
You may qualify if:
- Partially edentulous patients.
- Kennedy class I or II in the upper jaw, from first premolar to second molar.
- Less than 5 mm of residual crestal bone.
- Need for the replacement of teeth with dental implants.
You may not qualify if:
- Sinus pathology (sinusitis, mucocele, cysts).
- Smokers.
- Previous long-term (\>3 months) use of drugs known to affect bone metabolism, such as bisphosphonates.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universidad de Granadalead
- University of Valenciacollaborator
Study Sites (2)
University of Granada
Granada, 18071, Spain
Universidad de Valencia
Valencia, 46010, Spain
Related Publications (4)
Galindo-Moreno P, Hernandez-Cortes P, Mesa F, Carranza N, Juodzbalys G, Aguilar M, O'Valle F. Slow resorption of anorganic bovine bone by osteoclasts in maxillary sinus augmentation. Clin Implant Dent Relat Res. 2013 Dec;15(6):858-66. doi: 10.1111/j.1708-8208.2012.00445.x. Epub 2012 Feb 29.
PMID: 22376122BACKGROUNDOrtega-Oller I, Del Castillo-Santaella T, Padial-Molina M, Galindo-Moreno P, Jodar-Reyes AB, Peula-Garcia JM. Dual delivery nanosystem for biomolecules. Formulation, characterization, and in vitro release. Colloids Surf B Biointerfaces. 2017 Nov 1;159:586-595. doi: 10.1016/j.colsurfb.2017.08.027. Epub 2017 Aug 24.
PMID: 28854415BACKGROUNDGalindo-Moreno P, Avila G, Fernandez-Barbero JE, Aguilar M, Sanchez-Fernandez E, Cutando A, Wang HL. Evaluation of sinus floor elevation using a composite bone graft mixture. Clin Oral Implants Res. 2007 Jun;18(3):376-82. doi: 10.1111/j.1600-0501.2007.01337.x. Epub 2007 Mar 12.
PMID: 17355356BACKGROUNDGalindo-Moreno P, de Buitrago JG, Padial-Molina M, Fernandez-Barbero JE, Ata-Ali J, O Valle F. Histopathological comparison of healing after maxillary sinus augmentation using xenograft mixed with autogenous bone versus allograft mixed with autogenous bone. Clin Oral Implants Res. 2018 Feb;29(2):192-201. doi: 10.1111/clr.13098. Epub 2017 Oct 26.
PMID: 29071736BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Antonio J Flichy-Fernandez, DDS
University of Valencia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full Professor of Oral Surgery and Implant Dentistry
Study Record Dates
First Submitted
March 15, 2018
First Posted
March 22, 2018
Study Start
February 1, 2012
Primary Completion
March 1, 2014
Study Completion
March 1, 2017
Last Updated
March 22, 2018
Record last verified: 2018-03
Data Sharing
- IPD Sharing
- Will not share